Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical immunology 2018-02, Vol.38 (2), p.166-173
Hauptverfasser:	Michniacki, Thomas F., Hannibal, Mark, Ross, Charles W., Frame, David G., DuVall, Adam S., Khoriaty, Rami, Vander Lugt, Mark T., Walkovich, Kelly J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Adenosine deaminase Adenosine Deaminase - deficiency Anemia, Aplastic - diagnosis Anemia, Aplastic - drug therapy Anemia, Aplastic - etiology Biomarkers Biomedical and Life Sciences Biomedicine Biopsy Bone marrow Bone Marrow - pathology Bone Marrow Diseases - diagnosis Bone Marrow Diseases - drug therapy Bone Marrow Diseases - etiology Bone tumors Hematologic Tests Hemoglobinuria, Paroxysmal - diagnosis Hemoglobinuria, Paroxysmal - drug therapy Hemoglobinuria, Paroxysmal - etiology Humans Immunology Immunosuppressive Agents - therapeutic use Infectious Diseases Intercellular Signaling Peptides and Proteins - deficiency Internal Medicine Letter to Editor Male Medical Microbiology Middle Aged Severe Combined Immunodeficiency - diagnosis Severe Combined Immunodeficiency - etiology Symptom Assessment Treatment Outcome Tumor Necrosis Factor-alpha - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!